ZNF161 Activators
ZNF161 Activators encompass a diverse array of chemical compounds that indirectly enhance the functional activity of ZNF161 through various signaling pathways. Forskolin is significant for its role in raising intracellular cAMP levels, subsequently activating PKA, which is known to phosphorylate substrates that may interact with ZNF161, thereby potentially enhancing its transcriptional regulatory capacity. Similarly, Epigallocatechin gallate, by inhibiting protein kinases, could reduce phosphorylation-mediated competition, allowing ZNF161 to bind more effectively to its target DNA sequences. Phorbol 12-myristate 13-acetate (PMA) influences the protein kinase C (PKC) pathway, which may enhance ZNF161's function by phosphorylating co-regulators of transcription. Ionomycin, through its ability to increase intracellular calcium levels, can activate calcium-dependent kinases, thereby potentially augmenting ZNF161's transcriptional activity.
Sphingosine-1-phosphate, through its targeted effects on cellular signaling, facilitates an environment that enhances ZNF161's transcriptional capabilities by modulating the activity of co-regulators and preventing inhibitory phosphorylations. Thapsigargin's elevation of cytosolic calcium can activate crucial signaling pathways, indirectly enhancing ZNF161's transcriptional functions. Lastly, Genistein's inhibition of tyrosine kinases could foster an increased activity of ZNF161 by alleviating the competition for DNA binding sites, thus indirectly promoting the transcriptional efficacy of ZNF161.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels which, in turn, activate PKA. PKA phosphorylation can enhance the transcriptional regulatory functions of ZNF161 by modifying the nuclear proteins that interact with ZNF161. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate inhibits several protein kinases, potentially reducing competitive phosphorylation events and enhancing ZNF161's ability to bind to its DNA recognition sequences more effectively. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which may phosphorylate transcription factors and co-regulators, thus potentially enhancing the transcriptional activity of ZNF161. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin raises intracellular calcium levels, which can activate calcium-dependent protein kinases that modulate transcription factor activity, possibly leading to enhanced ZNF161 function. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate activates sphingosine kinase, leading to downstream effects on transcription factor regulation, potentially enhancing ZNF161's role in gene expression. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin increases cytosolic calcium concentration, which may activate calcineurin and other calcium-dependent signaling pathways, potentially enhancing the transcriptional activity of ZNF161. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that by reducing competitive tyrosine kinase signaling, may indirectly enhance the activity of ZNF161 by allowing for better access to the DNA binding sites and promoter regions. | ||||||